NASDAQ: FBRXRUSSELL2000
Forte Biosciences, Inc.
Healthcare · Biotechnology · Headquartered in Dallas, US
Price
Loading chart…
Overview
Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.
History & business model
This section is waiting to be written.
InvestWiki is community-edited. Contribute a plain-English history of Forte Biosciences, Inc., its business model, key products, and controversies.